SCHEMBL25747852

SCHEMBL25747852

COc1ccc2[nH]cc(C(=O)C(=O)N(C)C)c2c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.39
▸ HTR1A P08908 1/20 0.38
▸ MTNR1A P48039 2/20 0.37
▸ MTNR1B P49286 2/20 0.37
▸ NR4A2 P43354 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ CTNNB1 P35222 1/20 0.35
▸ WNT3A P56704 1/20 0.35
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRB1 P18505 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ GABRA3 P34903 1/20 0.35
▸ GABRA2 P47869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31077729 1.00 MAPK14 (0.39) MAPK14HTR1AMTNR1AMTNR1BNR4A2
SCHEMBL25436706 0.87 ALDH1A1 (0.38) HTR1AMTNR1AMTNR1BALDH1A1LMNA
SCHEMBL25747864 0.87 HTR1A (0.35) HTR1AMTNR1AMTNR1BNR4A2ALDH1A1
SCHEMBL31077662 0.83 GABRP (0.41) MTNR1AMTNR1BNR4A2LMNAMAPT
SCHEMBL25289183 0.83 GABRP (0.41) MTNR1AMTNR1BNR4A2LMNAMAPT
SCHEMBL24746654 0.82 HTR6 (0.49) MAPK14HTR1AMTNR1AMTNR1BNR4A2
SCHEMBL25747868 0.82 MEN1 (0.36) MTNR1AMTNR1BALDH1A1GABRPGABRD
SCHEMBL17417724 0.81 PRKAB2 (0.46) MTNR1AMTNR1BNR4A2ALDH1A1MAPT
SCHEMBL25748082 0.81 NR4A2 (0.36) MAPK14NR4A2ALDH1A1LMNAMAPT
SCHEMBL25438139 0.78 NR4A2 (0.39) MAPK14MTNR1AMTNR1BNR4A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB MAPK14 2602/4885HTR1A 185/4885MTNR1A 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback